By STEVEN ZECOLA
Congress will need to amend its faltering Parkinson’s disease legislation if it hopes to achieve meaningful results.
Why Change Is Necessary
For more than 50 years, the National Institutes of Health (NIH) has pursued Parkinson’s disease (PD) research with limited success. Nearly $5 billion has been spent, yet no approved treatment exists that slows, stops, or cures the disease.
This is not a new concern. By the mid‑1990s, Parkinson’s advocacy groups had grown frustrated by the absence of major therapeutic advances since L‑dopa’s approval 25 years earlier. That...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free